Four Ways to Win amid Uncertainty
Strong Supply Chains, Efficiency, Digitalization, and Talent Development are Crucial for Chemical Distributors

Global chemical distribution is entering a new phase, shaped by persistent macroeconomic uncertainty, rising tariff pressure, and intensifying demands for value in principal–distributor relationships. Geopolitical fragmentation, shifting trade flows, and evolving end-customer needs are prompting producers to rethink outsourcing strategies and consolidate around fewer, more capable strategic partners.
For distributors, given the current market circumstances, this is a moment to move beyond operational execution and become resilient, digitally enabled, and proactive strategic allies – leveraging capabilities in AI, regulatory expertise, and regional market adaptation. The impact, however, will differ sharply by region and between specialty and commodity segments. In this volatile environment, the ability to navigate disruption, deliver targeted value, and tailor strategies to segment-specific demands will define competitive advantage. Those investing early in resilience, depth of capabilities, and alignment with principal expectations will shape the industry’s next chapter.
Six Key Findings
Since 2012, we at BCG, have published a biyearly chemical distribution outlook report. Our analysis integrates insights from a survey of more than 300 leading chemical principals and interviews with over 20 distributors across regions and segments. We present six key findings that capture the strategic pressures and capability shifts transforming the chemical distribution landscape, setting the stage for four imperatives that will help distributors to win amid uncertainty.
Read more with free registration
Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.
Company
BCG The Boston Consulting Group GmbHLudwigstr. 21
80539 München
Germany
most read

US Tariffs Fatal for European Pharma
Trump's tariff policy is a considerable burden and a break with previous practice.

Q1 2025 Chemical Industry: Diverging Trends
The first quarter of 2025 highlights a continued divergence between the European and US chemical industries.

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance
The ECA Foundation, one of the most important not-for-profit organizations for regulatory expertise in the pharmaceutical industry, aims to become the largest independent GMP/GDP organization in the world.

ISPE Good Practice Guide: Validation 4.0
The Validation 4.0 Guide provides a comprehensive approach to ensuring product quality and patient safety throughout a pharmaceutical product's lifecycle.

Pharma 4.0—the Key Enabler for Successful Digital Transformation in Pharma
Part 3: Seven Theses for successful Digitalization in Pharma











